secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001493152-23-039171
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 3.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera raises $4.5M in registered direct offering, amends existing warrants to $3.55
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.5M from sale of 1,205,000 shares/pre-funded warrants and 1,807,500 common warrants.
- Common warrants exercisable at $3.55/share, expire 5 years from issuance; pre-funded warrants at $0.0001.
- Existing warrants for 385,236 shares amended to $3.55 exercise price and extended to November 2, 2028.
- Roth Capital Partners acted as placement agent; cash fee of 7% of gross proceeds plus expenses.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223039171/0001493152-23-039171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223039171/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer